HER2 and CDK4 regions were analyzed in both adenocarcinoma and neuroendocrine carcinoma components of Ov-MiNEN and neither HER2 nor CDK4 amplification was observed, albeit polysomies of chromosomes 12 and 17 were found. This evidence concerns the gene ERBB2 and adenocarcinoma.